Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Walker Luke Nathaniel Create: Alert

All | News | Filings
Date FiledTypeDescription
01/26/2023 4 Walker Luke Nathaniel (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 100,000 options to buy @ $0.89, valued at $89k
10/04/2022 4 Walker Luke Nathaniel (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 305,000 options to buy @ $1.08, valued at $329.4k
10/04/2022 3 Walker Luke Nathaniel (Chief Medical Officer) has filed a Form 3 on Harpoon Therapeutics, Inc.
03/13/2018 4 Walker Luke Nathaniel (SVP, Clinical Development) has filed a Form 4 on Cascadian Therapeutics, Inc.
Txns: Unknown transaction of 10,315 shares @ $0
Disposed/sold 2,500 options to buy @ $35.88, valued at $89.7k
Disposed/sold 334 options to buy @ $41.52, valued at $13.9k
Disposed/sold 1,250 options to buy @ $28.44, valued at $35.6k
Disposed/sold 2,500 options to buy @ $10.44, valued at $26.1k
Disposed/sold 1,250 options to buy @ $10.56, valued at $13.2k
Disposed/sold 5,834 options to buy @ $21.06, valued at $122.9k
Disposed/sold 8,334 options to buy @ $6.9, valued at $57.5k
Disposed/sold 20,834 options to buy @ $6.9, valued at $143.8k
Disposed/sold 35,100 options to buy @ $4.64, valued at $162.9k
Disposed/sold 50,000 options to buy @ $3.99, valued at $199.5k
02/14/2018 5 Walker Luke Nathaniel (SVP, Clinical Development) has filed a Form 5 on Cascadian Therapeutics, Inc.
02/02/2018 4 Walker Luke Nathaniel (SVP, Clinical Development) has filed a Form 4 on Cascadian Therapeutics, Inc.
Txns: Granted 130,000 options to buy @ $0
01/16/2018 4 Walker Luke Nathaniel (SVP, Clinical Development) has filed a Form 4 on Cascadian Therapeutics, Inc.
Txns: Paid exercise price by delivering 637 shares @ $3.92, valued at $2.5k
Exercised 1,950 options to buy @ $0
09/20/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/20/2017 3 Form 3 - Initial statement of beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy